... of invasive pneumococcal disease in those under the age of 5. [1] ( Figure ). The immune response to conjugate vaccine ... The Northern California Kaiser Permanente trials [5] determined the following outcomes: • Efficacy of the ... different from efficacy and was 93.9% (95% CI 79.6 to 98.5). The US initiated a pneumococcal conjugate vaccine program ...
... facial expressions. Recently, Levin and colleagues [5] studied a cohort of 125 adults with mild traumatic brain ... in a wide variety of sleep disorders. Doses range from 1.5 to 24 mg. General treatment strategies Lee and colleagues ...
... and the many problems that can stem from an mTBI. [5] Patients with stressful lives, difficult jobs, high ... Patients should be told about common mTBI symptoms, [5] be advised to take it easy for a while, and be warned ...